Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome
https://doi.org/10.14412/1995-4484-2004-799
Abstract
To study clinical significance of von Willebrand factor antigen (WFA) in antiphospholipid syndrome and systemic lupus erythematosus (SLE). Material and methods. Serum concentration of WFA was determined with immune-enzyme assay in 21 pts with primary APS (PAPS), 39 SLE pts with APS, 68 SLE pts and 56 healthy donors. Results. WFA level in PAPS, SLE+APS and SLE was significantly higher than in donors. WFA concentration in serum of SLE pts without APS significantly exceeded that in PAPS. WFA concentration elevation was revealed in 52,4% of PAPS, 56,4% SLE+APS and 73,5% SLE pts. There was no association between WFA level, thromboses and obstetric pathology in PAPS and SLE. WFA concentration increase in SLE with APS correlated with IgM anticardiolipin antibodies and SLEDAI activity index (p<0,05), in SLE - with SLEDAI and ECLAM activity indices (p<0,05). WFA level in SLE pts with renal disease was significantly higher than in SLE pts without renal disease. There was a direct correlation between WFA level and ESR (p<0,05) so as with CRP (p<0,05) in SLE. There were no significant differences of WFA level in SLE pts with and without atherosclerotic plaques. WFA level did not correlate with intima-media complex thickness. Conclusion. Development of immunopathological processin SLE and APS is associated with WFA hyper production. WFA elevated level reflects inflammatory activity of the disease in SLE but is not associated with presence of thrombotic and atherothrombotic complications in APS.
About the Authors
A A NovikovE N Alexandrova
T V Popkova
T M Reshetnyak
N G Klyukvina
D S Novikova
LB Slitivelband
A A Baranov
References
1. <div><p>Насонов Е.Л. Современные направления иммунологических исследований при хронических воспалительных и аутоиммунных заболеваниях человека. Тер, архив, 200i, 8, 43-46</p><p>Malik А.В., Lo S.K. Vascular endothelial adhesion molecules and tissue inflammation. Lab. Invest., 1996, 48, 213229</p><p>Cinez D.B., Poliak E.S., Buck C.A. et al. Endothelial cells in physiology an in the phatophysiology of vascular disorders. Blood. 1998, 91, 3527-3561</p><p>Salogin K.V,, Nasonov E.L., Belenkov Yu.N. The role of endothelial cell in immunopatology. Sov.Arch.Int.Med. 1992, 64. I, 16-24</p><p>Hahn B.N. Systemic lupus erythematosus and accelerated atherosclerosis. New.Engl.J.Med., 2003, 349, 2379-2380</p><p>Насонов Е.Л., Баранов A.A., Шилкина H П. Маркеры активации эндотелия (тромбомодулин, антиген фактора Вилебраида и аигиотензинпревращаюший фермент): клиническое значение. Клии.мед., 1998, II, 4-10</p><p>Mannucci P.M. Von Willebrand facor. A marker of endothelial damage? Arterioscler. Thromb. Vase. Biol., 1998, 18, 1359-1362</p><p>Lindsey N.L. Henderson F.J., Dowson R. et al. International Symposium on Antiphospholipid Antibodies, 5-th. San Antonio, 1992, 1-32</p><p>Lai K.N, Leung J.C, Lai KB. et al. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin. Immunol. Immunopathol., 1996, 81, 229-38</p><p>Баранов А.А., Насонов Е.Л., Шилкина Н.П. и др. Антиген фактора Виллебранда у больных ревматоидным васкулнтом: метод определения и клиническое значение. Тер.архив, 1993, 3, 69-73</p><p>Geggel R.L., Carvalho А.С., Hoyer L.W., Reid LM. von Willebrand factor abnormalities in primary pulmonary hypertension. Am. Rev. Respir. Dis., 1987,135,294-299</p><p>Баранов A.A. Клинико-иммунные аспекты патологии сосудов при системных васкулитах и некоторых ревматических заболеваниях, Автореф.дисс. д.м.н. Ярославль. 1998</p><p>Wagner D.D., Bonfanti R. Von Willebrand factor and the endothelium. Mayo.Clin.Proc., 1991, 66, 621-627</p><p>Насонов Е.Л., Саложин К.В., Штутман В.З. и др. Антитела к эндотелию, тромбомодулин и антиген фактора Виллебранда при полимиозите и дерматомиозите, Клин. мед. 1996, 6, 32-34</p><p>Калашникова Л.А., Насонов ЕЛ,, Баранов А.А. и др, Синдром Снеддона и антиген фактора Виллебранда. Клии.мед., 1994, 3, 24-27</p><p>Baranov А.А., Nassonov E.L., Shtutman V.Z. et al. Von Willebrand factor antigen in polymyositis/dermatomiositis: correlation with exiramuscular manifestation. IX EULAR Symposium. Madrid, 1996, p. 84.</p><p>Mackworth-Young C.G., Andreotti F., Harmer I. et al. Endothelial-derived haemostatic factors and the antiphospholipid syndrome. Brit.J. Rheumatol., 1995, 34, 201-206</p><p>Tan E.M., Cohen A.S., Fries J.F. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr., Rheum, 1982, 25,1271-1277</p><p>Wilson W. A., Azzudin E. Gharavi A.E, Koike T. et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthr. Rheum., 1999,42,1309-1311</p><p>Александрова E.H., Насонов Е.Л., Ковалев В.10. Количественный иммуноферментный метод определения антител к карлиолипину в сыворотке крови. Клин, рев- матол., 1986, 4, 35-39</p><p>Woolf A.D., Wakerley G., Wallington T.B. et al. Factor VIII related antigen in the assessment of vasculitis. Ann.Rheum.Dis., 1987. 46, 441-447</p><p>Nassonov E„ Baranov A., Kovaliov V. von Willebrand factor antigen and antiphospholipid antibodies in systemic lupus erythematosus. Clin,Exp. Rheumatol., 1994,. 12 (suppl 11), 97 (abst)</p><p>Roman M.J., Salmon J.E. Sobel R. et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am.J.Cardiol., 2001, 87(5), 663-666</p><p>Клюквина Н.Г. Баранов A.A. Александрова E.H. и цр. С-реактивный белок при системной красной волчанке: связь с тромботическими осложнениями. Клин, мед., 1997, 8, 24-27</p><p>Александрова Е.Н., Новиков А.А,, Решетняк Т.М. и др. Растворимые молекулы адгезии при антифосфолипидном синдроме, связанном с системной красной волчанкой, и первичном антифосфолипидном синдроме. Тер. архив, 2002, 5, 23-27</p></div><br />
Review
For citations:
Novikov A.A., Alexandrova E.N., Popkova T.V., Reshetnyak T.M., Klyukvina N.G., Novikova D.S., Slitivelband L., Baranov A.A. Von Willebrand factor antigen in systemic lupus erythematosus and antiphospholipid syndrome. Rheumatology Science and Practice. 2004;42(4):35-38. (In Russ.) https://doi.org/10.14412/1995-4484-2004-799
Views:
1205
Email this article 